Ajanta Pharma Q1 net profit rises 18% to Rs 246 crore
The company's US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal.Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
Ajanta Pharma on Tuesday said its consolidated profit after tax (PAT) increased 18 per cent year-on-year to Rs 246 crore for the June quarter, on account of robust sales across domestic and international markets.
The drug firm had reported a profit after tax of Rs 208 crore in the April-June quarter of last fiscal.
Revenue from operations rose to Rs 1,145 crore during the quarter under review as against Rs 1,021 crore in the year-go period, Ajanta Pharma said in a regulatory filing.The company said its India sales grew 10 per cent year-on-year to Rs 353 crore in the first quarter.
The company's US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal.Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
IRCTC Dividend 2024: Railway PSU announces 200% interim dividend - Check record date and other details
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
05:27 PM IST